Predictive value of urinary micro-cholesterol (mCHO) levels in patients with progressive glomerular disease Osamu Hotta, Hisako Sugai, Hiroshi Kitamura,

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Kamyar Kalantar-Zadeh Kidney International

Volume 54, Issue 2, Pages (August 1998)

Beta blockers in the management of chronic kidney disease

Renal manifestations in Fabry disease and therapeutic options

Anemia management in chronic kidney disease

Blaithin A. McMahon, Patrick Thomas Murray Kidney International

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

John P. Middleton, Patrick H. Pun Kidney International

Manjula Kurella, Jennifer Luan, Kristine Yaffe, Glenn M. Chertow

Volume 73, Issue 4, Pages (February 2008)

Kamyar Kalantar-Zadeh Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 70, Pages S21-S25 (December 2006)

How to interpret the eGFR in patients with small body surface area

Comorbidity and confounding in end-stage renal disease

Proinflammatory effects of iron sucrose in chronic kidney disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Body weight is a fluctuating parameter in hemodialysis patients

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Nephrology Crosswords: Hemodialysis

Volume 87, Issue 2, Pages (February 2015)

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 85, Issue 3, Pages (March 2014)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Urinary biomarkers: the future looks promising

Methods for guideline development

Volume 93, Issue 1, Pages (January 2018)

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 67, Issue 4, Pages (April 2005)

Counteracting progression of renal disease: A look into the future

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Laura M. Dember, Erika F. Holmberg, James S. Kaufman

The initiation and progression of sickle cell nephropathy

Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen

Keng-Thye Woo, Yeow-Kok Lau, Kok-Seng Wong, Gilbert Shih-Chen Chiang

Volume 71, Issue 4, Pages (February 2007)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Phosphate binders on iron basis: A new perspective?

Organ transplantation goes to the movies

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Volume 74, Issue 9, Pages (November 2008)

Volume 60, Issue 6, Pages (December 2001)

Is it the low-protein diet or simply the salt restriction?

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 70, Issue 5, Pages (September 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

The changing face of childhood nephrotic syndrome

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Volume 80, Issue 9, Pages (November 2011)

Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors Lynn Stothers, William A. Gourlay, Li.

Volume 55, Issue 5, Pages (May 1999)

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases Martina Franz, Wolfgang Woloszczuk,

Quiz page December 2003 American Journal of Kidney Diseases

Volume 56, Issue 4, Pages (October 1999)

Presentation transcript:

Predictive value of urinary micro-cholesterol (mCHO) levels in patients with progressive glomerular disease Osamu Hotta, Hisako Sugai, Hiroshi Kitamura, Naoko Yusa, Yoshio Taguma Kidney International Volume 66, Issue 6, Pages 2374-2381 (December 2004) DOI: 10.1111/j.1523-1755.2004.66026.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Correlations of urinary fatty body counts (ORO positive cells) with other urinary parameters. Kidney International 2004 66, 2374-2381DOI: (10.1111/j.1523-1755.2004.66026.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Correlation of serum cholesterol with urinary mCHO concentration. Kidney International 2004 66, 2374-2381DOI: (10.1111/j.1523-1755.2004.66026.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Comparison of receiver-operating characteristic (ROC) curves in predicting rapid progression. Rapid progression is defined as -Δ1/sCr/month >0.004 during the entire follow-up period. Kidney International 2004 66, 2374-2381DOI: (10.1111/j.1523-1755.2004.66026.x) Copyright © 2004 International Society of Nephrology Terms and Conditions